Steris PLC (N:STE)

Business Focus: Medical Equipment, Supplies & Distribution

Sector:  Healthcare Industry:  Medical Equipment, Supplies & Distribution
See Regulatory Filings on SEC
Company Contact
Address: Block a Riverside IV
70 Sir John Rogerson's Quay
Tel: 1-440-3927245
Website: N/A
Key People
Business Overview
Steris plc, formerly Steris Ltd, is a provider of infection prevention and other procedural products and services. The Company offers a mix of capital equipment products, such as sterilizers and washers, surgical tables, lights and equipment management systems and connectivity solutions, such as operating room integration; consumable products, such as detergents and gastrointestinal endoscopy accessories and other products; services, including equipment installation and maintenance, microbial reduction of medical devices, instrument and scope repair solutions, laboratory services and outsourced reprocessing. The Company operates through four reportable business segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. It's Corporate and other segment includes the Defense and Industrial business unit. The Company serves the customers in the United Kingdom, the United States and many other countries throughout the world.
Financial Overview
For the fiscal year ended 31 March 2019, Steris PLC revenues increased 6% to $2.78B. Net income before extraordinary items increased 12% to $304.1M. Revenues reflect Healthcare Products segment increase of 5% to $1.34B, Applied Sterilization Technologies segment increase of 8% to $555.1M, Health speciality services segment increase of 9% to $510.1M, United States segment increase of 8% to $1.98B.
Employees: 12,000 as of Mar 31, 2019
Reporting Currency: U.S. Dollars
Enterprise value: $12,836M as of Mar 31, 2019
Annual revenue (TTM): $2,782M as of Mar 31, 2019
EBITDA (TTM): $627.32M as of Mar 31, 2019
Net annual income (TTM): $304.05M as of Mar 31, 2019
Free cash flow (TTM): $237.29M as of Mar 31, 2019
Net Debt Last Fiscal Year: $962.59M as of Mar 31, 2019
Shares outstanding: 84,552,259 as of May 30, 2019
Index Membership: S&P 400 Mid Cap
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization